Pharmacological treatment and perceived health status during 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization. Results from the Euro Heart Survey on Coronary Revascularization
about
Cost-effectiveness of new cardiac and vascular rehabilitation strategies for patients with coronary artery disease.A review of health utilities using the EQ-5D in studies of cardiovascular disease.Intramyocardial, autologous CD34+ cell therapy for refractory angina.Quality of life in female myocardial infarction survivors: a comparative study with a randomly selected general female population cohort.The European Council on Cardiovascular Nursing and Allied Professions: toward promoting excellence in cardiovascular care.A systematic literature review of cardiovascular event utilities.Epidemiology and pathogenesis of diffuse obstructive coronary artery disease: the role of arterial stiffness, shear stress, monocyte subsets and circulating microparticles.Long-term survival in patients with refractory angina.Research in cardiovascular care: a position statement of the Council on Cardiovascular Nursing and Allied Professionals of the European Society of Cardiology.A prospective study of patients with refractory angina: outcomes and the role of high-sensitivity troponin T.The effectiveness and cost-effectiveness of plant sterol or stanol-enriched functional foods as a primary prevention strategy for people with cardiovascular disease risk in England: a modeling study.Efficacy of cardiac shock wave therapy in patients with stable angina: The design of randomized, triple blind, sham-procedure controlled study.
P2860
Q33391049-95D5ACE0-A243-40A0-8476-B261DC3A64BAQ33669647-C53A4CE9-91FC-4B29-95D0-B60A878ADFEBQ35308043-E57456B8-EB30-42DB-8031-8C6FF2545AEEQ36327825-C8A3A645-9FF1-413D-9106-590B6E93FB16Q37024381-6B52AF80-FD9D-4CFB-B4A0-6C6B1E1F8C24Q38157041-F9281A4A-C5C5-41BD-BAC3-78C20BA144A7Q38860377-888BF8AF-E16F-45CE-BC2D-D25878BC82B9Q39227491-C1BA4CC3-E989-458B-A184-4CF42DC89352Q39326663-AB048E15-B63E-46E1-8D89-9C68BDA4DF25Q40535232-9B2BD5DB-756F-4164-BC2E-E2E325DFCFADQ47624902-3CCE2934-01E6-4C9B-A90A-0C9EFDF259B1Q50101459-DA070CC8-3660-4AFA-9C82-FB3A3272EC5B
P2860
Pharmacological treatment and perceived health status during 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization. Results from the Euro Heart Survey on Coronary Revascularization
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Pharmacological treatment and ...... on Coronary Revascularization
@ast
Pharmacological treatment and ...... on Coronary Revascularization
@en
Pharmacological treatment and ...... on Coronary Revascularization
@nl
type
label
Pharmacological treatment and ...... on Coronary Revascularization
@ast
Pharmacological treatment and ...... on Coronary Revascularization
@en
Pharmacological treatment and ...... on Coronary Revascularization
@nl
prefLabel
Pharmacological treatment and ...... on Coronary Revascularization
@ast
Pharmacological treatment and ...... on Coronary Revascularization
@en
Pharmacological treatment and ...... on Coronary Revascularization
@nl
P2093
P2860
P50
P1476
Pharmacological treatment and ...... on Coronary Revascularization
@en
P2093
Anna Strömberg
Bengt Fridlund
Jan Mårtensson
Johanna Heikkilä
Karen Smith
Mattie Lenzen
Tone M Norekvål
Wilma Scholte op Reimer
P2860
P304
P356
10.1016/J.EJCNURSE.2006.01.003
P407
P577
2006-03-10T00:00:00Z